Latest News and Press Releases
Want to stay updated on the latest news?
-
We have filed a class action lawsuit on behalf of Morphic shareholders alleging securities claims in connection with the proposed sale to Eli Lilly.
-
We are investigating the fairness of the proposed sale of Morphic Holding to Eli Lilly for $57.00 per share in cash in a tender offer.
-
Morphic Under Investigation: Shareholders Are Encouraged to Contact Johnson Fistel for Their Options
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ: MORF), any of its...